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Abstract 
Objective: This study aimed to examine the effect of perceived diagnostic delay on cancer-related 
distress, and determine whether fear of cancer-recurrence and quality of life mediate this 
relationship. 
Methods: Cross-sectional study in which 311 colorectal cancer (CRC) survivors in Scotland 
completed a survey which included questions on cancer-related distress (IES-R), perceived 
diagnostic delay, quality of life (trial outcome index of the FACT-C: FACT-C TOI) and fear of 
cancer recurrence. 15 patients withheld consent to data matching with medical records, leaving a 
sample size of 296. Participants were an average of 69 years old (range 56 to 81) and between 3.5 to 
12 years post-diagnosis. Multiple regressions were used to test predictors of distress, and regression 
and  bootstrapping was used to test for mediation. 
Results: Perceived diagnostic delay was correlated with higher cancer-related distress, while 
objective markers of diagnostic delay (disease stage at diagnosis and treatment received) were not. 
Some of the relationship between perceived diagnostic delay and cancer-related distress was 
mediated by quality of life, but not by fear of cancer recurrence.  
Conclusions: Perceived diagnostic delay was associated with higher cancer-related distress among 
CRC survivors. While poorer quality of life partly explained such associations, fear of cancer 
recurrence, stage at diagnosis and treatment did not. The exact features of diagnostic delay that are 
associated with cancer-related distress remain unclear. Future research should examine the 
experiences patients go through prior to diagnosis that may increase distress, in an effort to improve 
our understanding of the factors affecting emotional wellbeing among CRC survivors.   
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Background 
Earlier stage at diagnosis is strongly associated with improvements in cancer survival (1)[1]. 
Consequently a number of initiatives have been introduced to try and reduce diagnostic delay among 
both patients (2)[2] and health-care providers (3)[3], with the emphasis on improving prognosis. 
However, little research has examined the psychological benefits of reducing diagnostic delay. A 
cancer diagnosis is always distressing, but the impact may be even worse if patients believe the route 
to diagnosis has been inefficient.  
 
There are a number of reasons to expect adverse psychological effects as a result of diagnostic delay. 
Higher distress has been observed among people with more advanced disease (e.g. [11], 
There are a number of reasons to expect adverse psychological effects as a result of diagnostic delay. 
Qualitative research into the experience of having colorectal cancer (CRC) diagnosed at flexible 
sigmoidoscopy screening found that many people described the diagnosis as relatively untraumatic,  
due to the absence of a period of symptoms and associated worry about a potential cancer diagnosis, 
and simpler treatment which often involved surgery alone (4) [4]. While receiving the actual 
diagnosis has been identified as the most stressful aspect, periods of waiting are also high on the list 
(5), and research in lung cancer patients found that a more rapid diagnosis was associated with less 
distress (6).  
Recent research in lung cancer patients found that a more rapid diagnosis was associated with less 
distress [5]. 
 
 
The need to identify and manage distress among cancer survivors is increasingly recognised, with 
calls to integrate psychological assessment into routine care (7)[6; 7](8). Psychological difficulties 
following a cancer diagnosis include depression, anxiety, and stress-related responses including post-
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traumatic stress disorder (PTSD). Such difficulties are often comorbid among cancer survivors (9) 
(10).  While symptoms of full-PTSD are typically less frequent than those of depression and anxiety, 
they are found in a significant minority of cancer survivors (e.g. (11-13)], with much higher rates of 
sub-threshold symptoms (e.g. 33% (5; 13). In addition, tConsequently, there have been specific calls 
for more research into factors that can increase vulnerability to cancer-related distress post-traumatic 
stress disorder (PTSD) (e.g. 11)[8]. .  Symptoms of traumaPTSD comprise avoidance, intrusive 
thoughts,  and hyper-arousal, and reflect subjective distress in relation to a traumatic event. The 
presence of a specific cluster of symptoms or symptom intensity (indexed by cut-off scores) can be 
used to identify PTSD. , and are found in a significant minority of cancer survivors (e.g. [8; 9]. 
While a number of demographic and clinical correlates of cancer-related distress have been 
identified, with higher cancer-related distress among younger people (14-16) [10-12], a more recent 
diagnosis (17)[13], and patients with more advanced disease (11)[8], the effect of diagnostic delay 
has received little attention.  One exception is a study which found higher distress among people 
with longer objective markers of delay in diagnosis and treatment (18)[14]. 
 
There are a number of ways in which delay could affect distress. Patients may be concerned that any 
delay in diagnosis has resulted in more advanced disease and necessitated more toxic or invasive 
treatments, and higher distress has been linked with more advanced disease (e.g. (15)), and the need 
for more complex treatment (19). In addition, the belief that there has been a delay in diagnosis could 
also increase fears of cancer recurrence, and raise concerns that the cancer and its treatment have had 
an unnecessarily adverse effect on the individual’s quality of life. 
 
Perceived delay in diagnosis could influence cancer-related distress in a number of different ways. 
Patients may be concerned that any delay has resulted in more advanced disease at diagnosis and 
necessitated more toxic or invasive treatments; as a result of which fears of recurrence may be 
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increased alongside concern that the cancer and its treatment have had an adverse effect on the 
individual’s quality of life.  The cognitive model of persistent PTSD forwarded by Ehlers and Clark 
(20) proposes that persistent PTSD occurs only if “individuals process the trauma in a way that leads 
to a sense of serious, current threat”, and that this can come from “excessively negative appraisals of 
the trauma and/or its sequelae.” Fear of cancer recurrence (FCR) refers to fear that cancer could 
come back, or progress, in either the same place or in another part of the body, and researchers have 
argued that FCR  provides a sense of current serious threat and can hence lead to post-traumatic 
symptomatology (21). Consistent with this view, previous research has documented strong 
associations between FCR and cancer-related distress (21; 22). It can also be argued that excessively 
negative appraisals of the sequelae of cancer can also be indexed by patients’ assessment of their 
quality of life. Quality of life is a multidimensional construct, comprising self-reported physical, 
functional, social/family, and emotional wellbeing (23). Previous research has shown PTSD 
responses are associated with both poor social functioning (12; 24; 25) and reduced physical 
functioning (12; 25-27). Hence according to this model and previous research findings, both FCR 
and quality of life could mediate associations between diagnostic delay and distress. 
Higher distress has been observed among people with more advanced disease (e.g. [11], greater fears 
about a cancer recurrence [15], and reduced physical functioning [16], and all of these could explain 
associations between perceived delay and cancer-related distress.  
The present study aimed to examine the predictors of cancer-related distress among patients with 
CRC and test mediational pathways between perceived delay and cancer-related distress. We 
hypothesized that: 
1) Cancer-related distress would be higher among CRC patients who perceived there had been 
delay in their diagnosis. 
2) Fear of recurrence and quality of life would contribute to explaining associations between 
perceived diagnostic delay and cancer-related distress, over and above any contribution of 
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stage at diagnosis and treatment received. 
 
Ethical approval  
Ethical approval was obtained from Riverside Research Ethics Committee (reference number: 
09/H0706/41). Approval for identifying potential participants via database linkage was granted by 
the NHS National Services Scotland Privacy Advisory Committee and the NHS Scotland 
Community Health Index Advisory Group. 
 
Materials and Methods 
Design and setting:  
Cross-sectional study, examining people diagnosed with CRC in Scotland between 2000-2008. 
 
Participants and recruitment: 
Potential participants were identified by linking the Scottish Cancer Registry and Scottish Colorectal 
Cancer Screening Pilot databases by their Community Health Index (CHI) number. The CHI 
database was used to identify patients and GP details. The CHI is a unique identifier for individuals 
registered at general practices in Scotland, and contains information on date of birth and gender. 
Practitioner Services Division at NHS National Services Scotland (NSS) co-ordinated patient contact 
via their GPs. Patients identified as deceased, or as having moved from the area, were excluded. 
Practitioner Services Division were given template letters for GPs and patients; they added GP and 
patient details, and forwarded the letters to the GPs to pass on to eligible patients. This process was 
approved by the Riverside Research Ethics Committee, NHS NSS Privacy Advisory Committee, and 
the NHS NSS Community Health Index Advisory Committee.  GPs were asked to confirm the 
diagnosis of CRC, and exclude patients who were deceased or terminally ill, unable to speak or read 
English, or lacked the capacity to take some or all decisions for themselves because of mental 
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disorder or inability to communicate. The first survey was sent to GP practices to be forwarded to 
patients in June 2012 and the reminder survey for non-responders, for eligible patients who had not 
yet returned a questionnaire, was sent to GPs in September 2012. Patients had their CRC diagnosed 
at FOBt screening or outside of screening (either following a negative screening result or because 
they lived outside the areas of the Scottish Pilot). Differences in psychological outcomes in relation 
to diagnostic pathway have been reported elsewhere (28)[17].  
 
Measures 
Age, gender, Scottish Index of Multiple Deprivation (SIMD) (29)[18], Dukes’ stage at diagnosis, 
treatment received (surgery, radiotherapy, chemotherapy) and time since diagnosis (in years) were 
supplied by NHS NSS with patient consent. All other variables were measured in the questionnaire. 
Employment status was assessed, and  with response options ‘employed full-time’, ‘employed part-
time’, ‘unemployed’, ‘self-employed’, ‘retired’, ‘full-time homemaker’, ‘disabled or too ill to work’, 
‘still studying’, ‘prefer not to say.’ Eethnicity was measured using questions from the Scottish 
Census 2011 (30)[19] with the addition of a ‘Prefer not to say’ response option. Co-morbidities were 
self-reported and combined into a single variable ‘comorbidity’ (Yes/No) (people were asked ‘Do 
you have, or have you ever had, any of the following diseases? Please tick any that apply.’ Response 
options were: ‘heart or vascular disease’, ‘diabetes’, ‘epilepsy’, ‘stroke’, ‘arthritis’, ‘asthma’, ‘mental 
or emotional disorder’, ‘cancer (other than bowel cancer)’, ‘any other illness, please specify (open-
ended)’.  Cancer recurrence was assessed with the item: ‘Has the cancer come back (recurred) since 
your first treatment? Yes, no, I don’t know / can’t remember.  If yes, in what part of the body? (open-
ended).’ 
 
The main outcome variable was current cancer-related distress, measured by the Revised Impact of 
Events Scale (IES-R) (31)[20] which has three subscales: intrusion, avoidance, and hyperarousal, as 
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well as a total score, with higher scores indicating higher levels of cancer-related distress. The IES-R 
can be used to measure distress (range 0-88) or suspected presence of PTSD (scores of 33 or higher).  
The IES-R was chosen because it is one of the most commonly used measures of cancer-related 
distress (32), with scale items directly corresponding to 14 of the 17 symptoms of PTSD outlined in 
DSM-IV (33) (the DSM version in use at the time of the study). Participants were asked to indicate 
how they had been feeling during the past seven days with respect to their cancer. 
 
The main predictors was perceived diagnostic delay: “Do you think your cancer could have been 
diagnosed sooner than it was” with response options: “yes”, “not sure”, and “not sure”, and was 
entered into analyses as an ordinal variable. Quality of life and FCRfear of cancer recurrence were 
potential mediators. Quality of life at the time of study participation (i.e. over the preceding seven 
days) was assessed using the FACT-C (34)[21]. This is a 34 item questionnaire that generates four 
wellbeing subscales: physical, functional, social/family, and emotional, which can be summed to 
form a general score (the FACT-G) allowing comparisons to be made across cancer types, and an 
additional CRC subscale which, along with the other subscales, forms a colorectal-cancer specific 
measure (the FACT-C). To reduce conceptual overlap with cancer-related distress, we used the Trial 
Outcome Index (FACT-C TOI), which sums the physical, functional and CRC subscales.  
 Fear of cancer recurrencee (FCR) at the time of the study was assessed using a four item scale 
(35)[22] with the wording altered to ask about CRC (called bowel in the questionnaire as that is the 
common term in the UK) rather than breast cancer: “How often have you worried about getting 
bowel cancer again” “How often have worries about getting bowel cancer again affected your 
mood”, “How often have worries about getting bowel cancer again affected your ability to carry out 
your daily activities”, and “How concerned were you about getting bowel cancer again” Response 
options were: “Not at all or rarely”, “sometimes”, “often”, “a lot”. Participants were asked to rate 
their concerns over the past month, and.  the scale showed good levels of internal reliability 
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(Cronbach’s alpha = 0.773). 
 
Statistical analysis 
Predictors of cancer-related distress were examined using linear and logistic regression. Potential 
mediators of the link between perceived diagnostic delay and cancer-related distress were assessed 
using the software Mplus 7.11, and the robust weighted least squares estimation technique (36)[23]. 
 
 
Response rate 
GPs were sent research invitation letters for 675 patients, of whom 142 were not contacted because 
the GP indicated that the patient met one or more of the exclusion criteria (n=70), or the GP did not 
wish to participate in the research (n=72); leaving 533 patients who were (apparently) mailed a 
questionnaire. Patients were invited to return the questionnaire blank if they did not wish to 
participate, but unless the questionnaire was returned, there was no way of confirming that it had 
definitely been forwarded to the patient. Assuming that all non-returned questionnaires had been 
mailed out, the questionnaire response rate was 58.3% (N=311), of whom 15 withheld consent for 
data-matching to NSS.  This left 296 as the sample for analysis; a response rate of 55.5%.   
 
Missing data 
Scores on the IES-R, FACT-C and fear of cancer recurrenceFCR scale were only computed if 
patients had answered at least 50% of the items otherwise they were recorded as missing. Missing 
data were 5% or higher for Dukes’ stage, receipt of radiotherapy, and the FACT-C TOI, but less than 
5%  for all the other variables (see Table 1). The mediation analysis was conducted both with 
completed data and with data imputed for missing values. 
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Results 
Background variables 
Descriptive and clinical characteristics of the whole sample are shown in Table 1. The average age 
was 69 years, ranging from 56 to 81; consistent with the age of invitation to the Scottish CRC 
Screening Pilot (50-69) and time since diagnosis. Time since diagnosis ranged from 3.5 to 12 years.  
Half the sample (49%) were men, almost all described their ethnicity as white (99%) and the 
majority were retired from work (75%). Participants were less deprived than the general population 
of Scotland, with over 20% in each of the higher quintiles.   
 
Predictor and outcome variables 
Perceived diagnostic delay was significantly correlated with receiving chemotherapy (r=0.204; 
p<0.001) and radiotherapy (r=0.122; p=0.044). The correlation with duke’s stage at diagnosis 
approached significance (r=0.120; p=0.055). 
They reported similar quality of life scores as in other studies of people with CRC [21; 24].  On the 
IES-R, 6% scored 33 or higher, indicating the likely presence of PTSD, consistent with findings from 
other studies. Rates of PTSD among cancer patients vary across studies, but using symptom 
checklists of ratesrates tend to range from between 5-12% (27).[25] (see Table 1).Participants 
reported similar quality of life scores compared with other studies of people with CRC (34; 37), 
equivalent to those reported by colorectal cancer survivors with no evidence of disease  (38).  Cut-off 
scores indicating poor quality of life have been published for the FACT-G (although not the FACT-
C), and 19% of the current sample reported poor quality of life (38) (see Table 1). Clinical cut-off 
scores for FCR have not been developed (39), but average scores were low, with 13.1% of 
participants reporting an average score of 2 or more, and only 1.4% reporting an average score of 3 
or more. 
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Predictors of cancer-related distress 
In univariate analyses, younger age, female gender, greater deprivation, presence of comorbitiies, 
shorter time since diagnosis, perceived diagnostic delay, greater FCRfear of recurrence and worse 
FACT-C TOI  scores were associated with higher experienced distress. Average level of distress by 
perceived diagnostic delay showed a linear trend across the three points of the scale (no: 8.31; not 
sure: 11.49; yes: 13.78). When all these variables were entered into the model, only age, perceived 
diagnostic delay, FCRfear of recurrence and FACT-C TOI scores remained significant predictors 
(see Table 2).  Using suspected PTSD caseness as the outcome (yes/no), age, deprivation, time since 
diagnosis, perceived diagnostic delay, FCRfear of recurrence, and FACT-C TOI were significant 
predictors. However in multivariate analyses, only perceived diagnostic delay and FACT-C TOI 
were significant predictors of cancer-related patient distress (see Table 3). 
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Mediation analysis 
In order to test whether FCRfear of recurrence or quality of life mediated the relationship between 
perceived diagnostic delay and cancer-related distress, variables that predicted cancer-related distress 
in multivariate analyses were entered into a model (see Figure 1).  Correlations between these 
variables are shown in Table 3.  The product of regression coefficients (used to calculate indirect 
effects) often violates the assumption of a normal distribution, potentially leading to biased results, 
so bias-corrected bootstrapping (N=5000) was used to generate confidence intervals around the 
mediation analyses (40)[26].  As shown in the Figure 1, quality of life (FACT-C TOI) mediated 
some of the relationship between perceived diagnostic delay and cancer-related distress, but there 
was no pathway from perceived diagnostic delay to distress via fear of cancer recurrenceFCR. The 
sample size of the current study was sufficient to detect medium effect-size associations between the 
predictor and mediator, and mediator and dependent variable, but was not powered to detect small 
associations (41). Theis model accounted for 546% of the variance in cancer-related distress. The 
indirect effect from perceived diagnostic delay to cancer-related distress via FACT-C TOI was 
significant using both non-imputed (0.052, CIs: 0.001 to 0.103, p=0.04523), as were the indirect 
effects between  and imputed data (0.050, CIs: 0.003 to 0.097, p=0.025).age and distress via both 
FCR (-0.105, CIs: -0.050 to -0.160, p<0.001) and physical, functional and colorectal quality of life (-
0.057, CIs: -0.006 to -0.109, p=0.029). All indirect effects remained significant using imputed data. 
There was a strong correlation between FCR and physical, functional and colorectal quality of life.  
 
 
Conclusions 
In line with our predictions, we found that cancer-related distress was higher among cancer survivors 
who reported diagnostic delay. However, nNeither disease stage at diagnosis nor treatment predicted 
distress, highlighting the fact that it was not the objective marker of disease progression, butshowing 
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it was the perception of delay, rather than objective markers, of delay that was associated with 
adverse psychological outcomes. When examining predictors of likely presence or absence of PTSD, 
only perceived diagnostic delay and poorer quality of life were significant emerged as significant 
predictors in multivariate analyses, confirming the importance of exploring perceived delay in the 
context of cancer distress.  
 
Mediation analysis showed that, in addition to a direct effect on cancer-related distress, perceived 
diagnostic delay also had an indirect effect via quality of life, but FCRfear of recurrence, although a 
significant predictor of distress, did not explain any of the association between perceived delay and 
cancer-related distress. However, the study was underpowered to detect  small mediation effects. 
This could be partly be the result of the length of time since diagnosis, with tThe majority of 
participants were diagnosed over five years prior to study participation, and . Cconcerns about the 
effect of diagnostic delay on cancer recurrence may have reduced as a result of over time with the 
realisation that any delay had not proved fatal.  
 
Consistent with previous research, we found that younger age was associated with higher levels of 
cancer-related distress (12). Part of this association was mediated by greater FCR and poorer self-
reported physical, functional and colorectal quality of life. Green et al (5) have speculated that 
negative associations between age and distress may be due to the more unexpected nature of the 
diagnosis, and greater impact on both the patient’s life and that of their family, as they may have 
young children. An additional explanation is that older people may have developed greater resilience 
to stress (42). Causes are likely to be multiple, but the present study confirms the need to be vigilant 
to the multiple cancer-related concerns that may exist among younger adults, including FCR and on-
going symptomatology and functional impairment. 
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A strong association was also observed between FCR and physical functional and colorectal quality 
of life. Lee-Jones et al (43) raise the possibility that FCR can lead to an increased focus on somatic 
symptoms. Similarly the presence of bodily symptoms could promote fears of a recurrence, and may 
explain the associations observed between these variables in the current study.  
 
 
To our knowledge, this is the first study to compare the effect of perceived diagnostic delay on 
psychological outcomes in the context of CRC (although see, although research is currently 
underway to look at the effect of diagnostic and treatment delay on quality of life and patient 
satisfaction (44) for details of a study in progress)[27].    
The present study benefits from validated measures of cancer-related distress and quality of life 
specific to colorectal cancer; and objective data on demographic and clinical characteristics. 
Weaknesses include the use of the IES-R to measure PTSD, as this measure does not align as closely 
with DSM criteria as other measures, such as the PCL-C, and cannot be used to diagnose full or sub-
threshold PTSD.  A further weakness is the retrospective assessment of perceived diagnostic delay. It 
could be argued that current levels of cancer-related distress or quality of life negatively influenced 
people’s judgments retrospective assessment aboutof diagnosic delay. , although aAgainst this 
argument is the lack of association between fear of cancer recurrenceFCR and perceived diagnostic 
delay, so there does not appear to be a global tendency to infer delay based on current distress and 
concerns.  
 
A further limitation is the cross-sectional assessment of variables, so while the mediational model 
presents a relationship from perceived diagnostic delay to cancer-related distress via quality of life, 
no firm causal inferences can be made.  Future research could help clarify the relationship by 
employing a prospective design measuring delay closer to the time of diagnosis, and its relationship 
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to the later development of cancer-related distress. Some limitations with the sample should also be 
noted: response rates were below 60%, the sample was less deprived than the general population of 
Scotland, and responders were almost exclusively of white ethnicity, thereby limiting the 
generalizability of the results to other ethnic groups and people with lower levels of literacy.  
 
Consistent with previous research we observed associations between higher cancer-related distress 
and younger age and a shorter time since diagnosis (12; 17)[9; 13], poorer quality of life (26)[16], 
and higher concerns about recurrence (21)[15]; but unlike previous research, we found no links with 
objective disease outcomes, such as stage at diagnosis or treatment and distress (12)[9]. The lack of 
association with stage of disease may be the result of small numbers of participants diagnosed with 
very late stage disease in this study. Gurevich et al (32) observed that only studies including patients 
with advanced disease showed an association between PTSD and stage at diagnosis, while in their 
meta-analysis Abbey et al (11) found higher rates of PTSD in studies that included patients with 
advanced stage disease.  
Reported rates of PTSD among cancer patients vary widely across studies, and method of 
assessment, with symptom checklists often resulting in higher rates than those determined by clinical 
interview. As noted in the results, the rate of PTSD in the current study is towards the lower end of 
that observed in previous research (27), most probably due to the sample skew towards earlier stage 
at diagnosis. This suggests that in practice, rates of PTSD are quite low among colorectal cancer 
survivors, at least several years post-diagnosis, but rates of both partial and full PTSD in patients 
shortly after diagnosis remain unknown. 
 
Cancer-related distress was higher among patients who believed there had been a delay in their 
diagnosis. However, the exact features of diagnostic delay that are associated with cancer-related 
distress remain unclear. 
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W While the role of disease stage at diagnosis and treatment received were examined, these factors 
did not explain associations between perceived delay and distress. 
 
When it comes to experiencing cancer as a traumatic stressor, new criteria for PTSD (in DSM-5) 
specify that “…a life-threatening… or debilitating medical condition is not necessarily considered a 
traumatic event. Medical incidents that qualify as traumatic events involve sudden, catastrophic 
events”. The severity of cancer as a stressor has typically been indexed by diagnostic stage and 
intensity of treatment (12)[9], however , disease stage and treatment variables did not explain 
associations between perceived delay and distress in the present study. Other factors associated with 
perceived diagnostic delay, such as intolerance of uncertainty or anxiety, may determine longer term 
psychological wellbeing rather than perceived diagnostic delay per se. Or it may be due to however 
the experiences patients go through prior to diagnosis have been neglected. A UK study of patients 
attending hospital appointments with specialists for prostate and bladder cancer diagnostic 
investigations reported that 31% of patients suffered clinical levels of anxiety – which were 
associated with their worry about their appointment and its outcomes (i.e. cancer diagnosis), their 
perceived social support and their personality (45)[28]. Differences in distress observed in the 
present study could relate to feelings associated with the perception of diagnostic delay per se (e.g. 
the belief there has been a medical error), or the experiences people go through that may be  
correlated with perceived delay, such as discovering symptoms which may take time to be 
diagnosed, or situations requiring urgent medical attention (e.g. emergency admission to hospital). 
Given the potential links between trauma and cancer progression [29] the need to understand and 
reduce factors that promote cancer-related distress in cancer survivors is a key area for future 
research and psychosocial intervention, and greater attention could be paid to the experiences 
patients go through prior to diagnosis that promote distress. 
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This study took place prior to the introduction of nationwide screening programmes for colorectal 
cancer in the UK. Screen-detected disease is associated with lower perceived diagnostic delay (28), 
and as rates of screening uptake increase, perceived delay and any associated distress will reduce. 
However, groups less likely to accept the offer of screening, such as people with higher levels of 
deprivation and ethnic minorities (46), are more vulnerable to the development of cancer-related 
stress as a result of their diagnostic pathway. 
 
Given the potential links between trauma and cancer progression (47)[29] the need to understand and 
reduce factors that promote cancer-related distress in cancer survivors is a key area for future 
research and psychosocial intervention, and greater attention could be paid to the experiences 
patients go through prior to diagnosis that promote distress. 
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 Table 1: Demographic, clinical and psychological characteristics (N=296) 
 % (n) 
Age when completed study  
50-59 4.4 (13) 
60-69 49.3 (146) 
70-79 44.6 (132) 
80+ 1.7 (5) 
Gender  
Male 49.3 (146) 
Female 50.7 (150) 
Scottish Index of Multiple Deprivation (fifths)   
1 (most deprived) 7.4 (22) 
2 16.9 (50) 
3 24.0 (71) 
4 26.7 (79) 
5 (least deprived) 24.0 (71) 
Missing 1.0 (3) 
Employment status  
Working (full-time, part-time, self-employed) 18.2 (54) 
Retired 74.3 (220) 
Other (home maker, students, unemployed, too ill to work/ disabled) 6.4 (19) 
Missing 1.0 (3) 
Ethnic group   
White  98.3 (291) 
Non-white 1.0 (3) 
Missing 0.7 (2) 
Time since diagnosis (years)  
3 to 4.9 11.1 (33) 
5 to 9.9 70.3 (208) 
10+ 18.6 (55) 
Dukes’ stage  
A 23.0 (68) 
B 35.1 (104) 
C 28.4 (84) 
D 2.0 (6) 
Missing 11.5 (34) 
Surgery   
Yes 96.6 (286) 
No 2.4 (7) 
Missing 1.0 (3) 
Radiotherapy   
Yes 12.5 (37) 
No 80.4 (238) 
Missing 7.1 (21) 
Chemotherapy   
Yes 40.2 (119) 
No 55.1 (163) 
Missing 4.7 (14) 
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Comorbidities  
Yes 70 (208) 
No 30 (88) 
Reported cancer recurrence following first diagnosis (both related 
and unrelated to initial bowel cancer diagnosis) 
 
Yes 8.4 (25) 
No 88.5 (262) 
Don’t know or can’t remember 1.0 (3) 
Missing 2.0 (6) 
Perceived diagnostic delay  
Yes 26.7 (79) 
Not sure 13.9 (41) 
No 58.4 (173) 
Missing 1.0 (3) 
Fear of cancer recurrence (1-4) mean (sd) 1.50 (0.54) 
Range: 1-4 
(n=291) 
Quality of life  
Overall quality of life (FACT-C total), mean (sd) 111.94 (17.21) 
Range: 41.10-136.00 
(n=266) 
Overall quality of life (FACT-G total), mean (sd) 89.8 (14.3) 
Range: 32.1 to 108.00 
(n=267) 
Proportion reporting low quality of life (FACT-G scores less than 78.8) 19.1 (51) 
(n=267) 
Physical, functional and colorectal subscales (FACT-C TOI) (0-84), 
mean (sd) 
69.78 (12.72) 
Range: 14.17-84.00 
(n=269) 
Cancer-related distress (IES-R)    
Total score (0-88), mean (sd) 10.23 (13.19)  
Range: 0 - 80.20 
(n=289) 
Avoidance (0-32), mean (sd)  4.70 (5.76) 
(n=289) 
Hyper-arousal (0-28), mean (sd)  
 
2.20 (4.11) 
(n=289) 
Intrusions (0-28), mean (sd) 3.34 (4.58) 
(n=289) 
Suspected PTSD caseness (participants scoring 33 or higher) 6 (17) 
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 Cancer –related distress as a 
continuous variable 
(standardized Beta weights) 
Cancer-related distress as a dichotomous 
variable: suspected caseness yes/no 
(ORs and 95% CIs) 
 Unadjusted  Adjusted d Unadjusted 
 
Adjusted d 
Demographic variables  
Age -0.267 c 
 
-0.117 a-0.105 a 0.88 [0.80 to 0.96] b 
 
0.89 [0.76 to 1.06] 
Gender 0.128 a 
 
0.0460.045 1.89 [0.68 to 5.25] 
 
- 
Scottish Index of Multiple Deprivation 
(higher score=less deprived) 
-0.150 b 
 
-0.038-0.038 0.57 [0.38 to 0.87] b 
 
0.68 [0.32 to 1.44] 
Comorbidities 0.157 b 
 
0.0740.067 3.35 [0.75 to 14.98] 
 
- 
Clinical variables 
Years since diagnosis -0.189 c 
 
0.0080.003 0.80 [0.63 to 1.02] + 
 
0.96 [0.57 to 1.60] 
Duke’s stage 0.035 
 
- 1.57 [0.76 to 3.22] 
 
- 
Radiotherapy 0.099 
 
- 2.42 [0.73 to 8.06] 
 
- 
Chemotherapy 0.049 
 
- 1.80 [0.65 to 4.98] 
 
- 
Self-reported episode of cancer 
recurrence (either related or unrelated 
to initial bowel cancer diagnosis) 
0.166 b 0.016 1.58 [0.34 to 7.39] - 
Psychological variables 
Fear of cancer recurrence 0.664 c 
 
0.413 c0.413 c 16.16 [5.94 to 43.97] c 
 
3.59 [0.64 to 20.17] 
Quality of life (physical, functional 
and colorectal) 
-0.608 c 
 
-0.351 c 0.87 [0.83 to 0.92] c 
 
0.87 [0.80 to 0.94] c  
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Table 2: Predictors of cancer-related distress   
 
+ p<0.10 
a p<0.05 
b p<0.01 
c p<0.001 
d adjusted for variables significant in univariate analyses 
 
 
 
 
 
Perceived diagnostic delay 0.183 c 
 
0.107 a0.108 a 2.20 [1.25 to 3.85] b 
 
3.87 [1.20 to 12.44] a 
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Table 3: Correlations between variables entered into the mediation model (imputed values given 
in brackets)  
 
 Age Perceived 
diagnostic delay 
Fear of cancer 
recurrence 
Quality of life 
(physical, 
functional, 
colorectal) 
Perceived diagnostic 
delay 
0.030 
(-0.005) 
1.00   
Fear of cancer 
recurrence 
-0.252 
(-0.266) 
0.083 
(0.082) 
1.00  
Quality of life 
(physical, functional, 
colorectal) 
0.152 
(0.168) 
-0.136 
(-0.136) 
-0.507 
(-0.530) 
1.00 
Cancer-related distress -0.260 
(-0.266) 
0.198 
(0.184) 
0.635 
(0.664) 
-0.609 
(-0.629) 
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